Catalog
About this item
Course/Activity Information
SNMMI/CBNM Webinar: Management Insights on Launching Radiopharmaceutical Therapy Programs in Community Settings: Is It a Wise Investment?
Technologist Member Fee: Free; Non-Member Fee: $32.00
Physician Member Fee: Free; Non-Member Fee: $49.00
Physicist Member Fee: Free; Non-Member Fee: $40.00
Pharmacist Member Fee: Free; Non-Member Fee: $40.00
Non-Credit Member Fee: Free; Non-Member Fee: $40.00
Release Date: March 11, 2025 Expiration Date: March 31, 2028
Presenter(s)
Megan Hungerford, Hartford Hospital
Christopher Smitherman, Hartford Hospital
Moderator(s)
Alexandru Bageac, MD, MBA
Tony Abraham, DO, MPA
| Name | Role | Disclosure |
| Megan Hungerford | Presenter | Hartford Hospital Nothing to disclose |
| Christopher Smitherman | Presenter | Hartford Hospital Nothing to disclose |
| Alexandru Bageac, MD, MBA | Moderator/ Organizer | Nothing to disclose |
| Tony Abraham, DO, MPA | Moderator/ Organizer | Nothing to disclose |
| The Community Based Nuclear Medicine Committee, reviewers and SNMMI Staff have indicated that they do not have a financial interest arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content presented. | ||
| Alexandru Bageac, MD, MBA | Community Based Nuclear Medicine Committee Co-Chairperson Nothing to disclose |
|
| Tony Abraham, DO, MPA | Community Based Nuclear Medicine Committee Co-Chairperson Nothing to disclose |
|
| Chair, Continuing Education Committee | ||
| CE Reviewer | ||
| Lisa Dickinson | SNMMI Staff, Education | |
| No Commercial Support was received for this activity. | ||
Financial Disclosure
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the SNMMI Conflict-of-Interest Policy, the speaker, moderator, organizers, planners, reviewers and staff have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.
Target Audience
Nuclear medicine physicians, technologists, physicists, and pharmacists.
Objectives
At the completion of this activity the participant will be able to:
1. Examine the three FDA approved PSMA ligands and their clinical indications.
2. Discuss differences in the biodistribution between these ligands.
3. Identify common pitfalls of the ligands.
Continuing Education Credit Information
To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment, and complete the evaluation. Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above.
Physician (AMA-PRA Category 1 Credits TM):
The Society of Nuclear Medicine and Molecular Imaging Inc., (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians. SNMMI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physicists
This activity offers 1.0 AMA PRA Category 1 CreditTM for physicists who complete the assessment and evaluation. 
Pharmacist (ACPE):
The Society for Nuclear Medicine and Molecular Imaging Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs.
Technologist (VOICE):
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. California Scope: 1.0 T (Therapy)
Minimum system requirements
Desktop
Mac OS 11, 12, 13
WBT makes every effort to test and support the most recent & stable versions of these web browsers: Apple Safari Version 11.x +; Google Chrome; Mozilla FireFox
Windows 10, 11
WBT makes every effort to test and support the most recent & stable versions of these web browsers: MS Edge; Google Chrome; Mozilla FireFox
Tablet/Smart Phone
iOS 12.x +
WBT makes every effort to test and support the most recent & stable version on the latest version of iOS: Safari, Google Chrome
Android 9+
WBT makes every effort to test and support the most recent & stable version on Android: Google Chrome, Native Android Browser, Mozilla FireFox
Recommendations and Requirements for All Browsers
- Enable Java, JavaScript, Cookies.
- Disable Pop-up Blockers
- The recommended minimum screen resolution on desktop is 1280 x 1024.
- The recommended minimum screen width resolution on iOS is 375px.
- The recommended minimum screen width resolution on Android is 400px.
- WBT Systems does not support beta versions of (supported) browsers.
- Plug-ins: Adobe Acrobat Reader (http://get.adobe.com/reader/)
Hardware Requirements:
- Computer: 1 GHz with 500 MB RAM or better
- Internet Connection: A broadband connection (DSL Cable etc.)
- Sound: Speakers or headset to hear audio
- Display: A display screen area of 800 x 600 pixels or higher
For questions please contact the Education Department at [email protected]
© 2025 SNMMI. All rights reserved. Policy on Privacy and Confidentiality